CSL Limited

ASX (AUD): CSL Limited (CSL)

Last Price

282.43

Today's Change

+1.80 (0.64%)

Day's Change

278.00 - 283.55

Trading Volume

147,861

Profile
CSL

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Paul F. McKenzie Ph.D. Dr. Paul F. McKenzie Ph.D.

Full Time Employees:  32,698 32,698

IPO Date:  1994-06-01 1994-06-01

CIK: 

ISIN:  AU000000CSL8 AU000000CSL8

CUSIP:  Q3018U109 Q3018U109

Beta:  0.30 0.30

Last Dividend:  3.97 3.97

Dcf Diff:  -362.56 -362.56

Dcf:  643.19 643.19

Description

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Address

45 Poplar Road,
Parkville, VIC 3052, AU

61 3 9389 1911

http://www.csl.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment